---
title: "Linagliptin - Diabetes mellitus type 2 - 4"
sidebar: mydoc_sidebar
permalink: db08882-mesh-d003924-4.html
toc: false 
---


Path ID: `DB08882_MESH_D003924_4`
{% include image.html url="images/db08882-mesh-d003924-4.png" file="db08882-mesh-d003924-4.png" alt="db08882-mesh-d003924-4" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000069476 | linagliptin | Drug |
| UniProt:P27487 | DPP-4 | Protein |
| UniProt:P09681 | glucose-dependant insulinotropic polypeptide (GIP) | Protein |
| UniProt:P01275 | glucagon | Protein |
| MESH:D006003 | glycogen | ChemicalSubstance |
| MESH:D005947 | glucose | ChemicalSubstance |
| MESH:D003924 | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Linagliptin | DECREASES ACTIVITY OF | Dpp-4 |
| Dpp-4 | INCREASES ACTIVITY OF | Glucose-Dependant Insulinotropic Polypeptide (Gip) |
| Glucose-Dependant Insulinotropic Polypeptide (Gip) | DECREASES ACTIVITY OF | Glucagon |
| Glucagon | DECREASES ABUNDANCE OF | Glycogen |
| Glycogen | DECREASES ABUNDANCE OF | Glucose |
| Glucose | TREATS | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB08882#mechanismofaction](https://go.drugbank.com/drugs/DB08882#mechanismofaction)
